glp-1 drug delivery devices RETHINKING DEVICES: DESIGNING FOR USERS BEYOND DIABETES Drug delivery system could reduce
Description
These results, usually up to three, are denoted as ads showing users that these are paid results
Available as: Last cited 8 Sept 2023 Ethics declarations Ethics approval and consent to participate Since it is a review article, they are not required
& Makin, V
So its a case of leapfrogging and iterative improvement
Medicines made from this hormone, known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), were originally designed to help those with type 2 diabetes to manage their blood glucose levels 2
2020;192:E87591
